Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Terminated1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT06418711Phase 3Terminated
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
MAC Lung DiseaseMycobacterium Infections, NontuberculousTreatment Refractory MAC Lung Disease
StudydirectorStart date: 2024-09-11

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jae-Joon Yim, MD

Seoul National University Hospital

Related
10 trials

Shared therapeutic areas:

Mycobacterium Infections, Nontuberculous
Similarity Score10%

Kevin L Winthrop, MD, MPH

Oregon Health and Science University

Related
5 trials

Shared therapeutic areas:

Mycobacterium Infections, Nontuberculous
Similarity Score10%

Gina Eagle

Insmed Incorporated

Related
1 trials

Shared therapeutic areas:

Mycobacterium Infections, Nontuberculous
Similarity Score10%

Christopher H. Goss, MD, MSc

University of Washington, Seattle Children's Hospital

Related
1 trials

Shared therapeutic areas:

Mycobacterium Infections, Nontuberculous
Similarity Score10%

Didier RENAUT

CHU Amiens-Picardie

Related
1 trials

Shared therapeutic areas:

MAC Lung Disease
Similarity Score10%

Grant Waterer, Prof.

Royal Perth Hospital

Related
1 trials

Shared therapeutic areas:

Mycobacterium Infections, Nontuberculous
Similarity Score10%

Jane E Gross, MD PhD

National Jewish Health

Related
1 trials

Shared therapeutic areas:

Mycobacterium Infections, Nontuberculous
Similarity Score10%

Jae-June Yim, MD

Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine

Related
1 trials

Shared therapeutic areas:

Mycobacterium Infections, Nontuberculous
Similarity Score10%

Patrick Flume

Medical University of South Carolina

Related
1 trials

Shared therapeutic areas:

Mycobacterium Infections, Nontuberculous
Similarity Score10%

Andrej Spec, MD

Washington University School of Medicine

Related
2 trials

Shared therapeutic areas:

Mycobacterium Infections, Nontuberculous
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06418711Phase 3StudyDirector

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

MAC Lung DiseaseMycobacterium Infections, NontuberculousTreatment Refractory MAC Lung Disease
Terminated

All 1 trials loaded